BCL2 and nasopharyngeal carcinoma: The combined nanoparticles upregulate the expression of Bax and Caspase 3 and downregulate the expression of apoptosis inhibitors Bcl-2 by 60% compared to control groups containing free Cisplatin, NPC, and NPC/miR-375.